Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05354323
Title NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NEC OncoImmunity AS
Indications
Therapies
Age Groups: adult | senior
Covered Countries LTU


No variant requirements are available.